Loperamide recalls
The FDA has published 2 recalls involving Loperamide since 2019. The latest was reported on 15 Jun 2022. Mckesson Medical-Surgical Inc. Corporate Office has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why loperamide is recalled
Companies
By year
All loperamide recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Loperamide Hydrochloride capsules, USP, 2 mg recalledLoperamide Hydrochloride | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS III | Loperamide HCL Tablets USP, 2 mg, Anti-diarrheal, 24 caplets recalledLoperamide Hydrochloride | Sun Pharmaceutical Industries | Other | OH |
Should you stop taking Loperamide?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.